Showing posts with label adults with moderately to severely active ulcerative colitis. Show all posts
Showing posts with label adults with moderately to severely active ulcerative colitis. Show all posts
Friday, July 27, 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

›
In continuation of my update on  Tofacitinib The U.S. Food and Drug Administration  expanded the approval of Xeljanz ( tofacitin...